dihydroxyphenylalanine has been researched along with Angiogenesis, Pathologic in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishikawa, T | 1 |
| Akiyama, N | 1 |
| Kunimasa, K | 1 |
| Oikawa, T | 1 |
| Ishizuka, M | 1 |
| Tsujimoto, M | 1 |
| Natori, S | 1 |
1 other study available for dihydroxyphenylalanine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Chick Embryo; Dihydroxyphenylalanine; Dose-Respo | 2006 |